We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

02 Jun 2026 - 04 Jun 2026
17 Jun 2026 - 19 Jun 2026
05 Oct 2026 - 06 Oct 2026

Puzzling Study Links Antibiotic Use to Breast Cancer

By HospiMedica staff writers
Posted on 24 Feb 2004
A large study has shown that women who take antibiotics have an increased risk of breast cancer. More...
The study was published in the February 16th issue of the Journal of the American Medical Association (JAMA).

Researchers used computerized pharmacy and breast cancer screening databases to compare antibiotic use of 2,266 women with breast cancer to similar information from 7,953 women without breast cancer. All were age 20 and over, and a wide variety of frequently prescribed antibiotics was examined. The results showed that the more antibiotics women took, the higher their risk of breast cancer. Women who took antibiotics for more than 500 days or had more than 25 prescriptions over an average period of 17 years had more than twice the risk of breast cancer as women who had not taken any antibiotics.

The researchers point out that the study does not mean that antibiotics cause breast cancer but only shows an association between the two. Similar results were found in a Finnish study of almost 10,000 women. More studies are required to examine whether specific indications for antibiotic use or times of use would affect the outcome. The authors say that antibiotics can affect bacteria in the intestine and affect how certain foods are broken down that may prevent cancer. Another hypothesis is that the effects of antibiotics on the body's immune response and response to inflammation could be related to the development of cancer. Still another is that underlying conditions leading to the need for antibiotics caused the increased risk, or that a weakened immune system is the cause of the association.

"This trial suggests another piece in the puzzle of factors that may potentially be involved in the development of breast cancer,” said Andrew C. von Eschenbach, M.D., director of the U.S. National Cancer Institute (NCI, Bethesda, MD, USA) and one of the authors. The other authors were from the Group Health Cooperative (GHC), the University of Washington, and the Fred Hutchinson Cancer Center, all in Seattle (WA, USA).


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Gold Member
12-Channel ECG
CM1200B
New
Creatinine/eGFR Meter
StatSensor® Creatinine/eGFR Meter
New
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The Elyra TFL System uses thulium fiber laser technology for efficient stone dusting and reduced stone migration, with an air-cooled design for quieter, more compact operation (photo courtesy of BD

BD Launches Elyra Laser Platform for Kidney Stone and Soft Tissue Procedures

BD (Becton, Dickinson and Company) has introduced the Elyra Thulium Fiber Laser (TFL) System, an advanced laser platform developed to complete its kidney stone care portfolio for urology teams.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.